Nine New MFN Pharma Agreements: What Is Actually Public So Far?
On August 31, 2026 the White House announced Most-Favored-Nation drug-pricing agreements with nine more manufacturers:
On August 31, 2026 the White House announced Most-Favored-Nation drug-pricing agreements with nine more manufacturers:
There is much more money available for biopharma and life sciences in Europe than there
We are delighted to announce that Javier Arribas has been promoted to Partner at Justin
The European Commission has recently announced that the first Joint Clinical Assessment (JCA) is finalised
“We don’t need to worry about Market Access, once we find a partner, they’ll take
In less than twelve months, the Trump administration turned a contested policy idea into a